Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Fens, Y. Gaarthuis, A. C. Bos, N. J. J. Schlösser, P. J. Sterk (Amsterdam, Utrecht, Zutphen, Netherlands). Exclusion of asthma for screening purposes using exhaled air molecular profiling by electronic nose. Eur Respir J 2011; 38: Suppl. 55, 4168

Member's Comments

No comment yet.

Related content which might interest you: External validation of exhaled breath molecular profiling in identifying COPD and asthma Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances Year: 2010 Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma. Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition? Source: Eur Respir J 2004; 24: Suppl. 48, 386s Year: 2004 Exhaled breath condensate analysis in diagnostics of occupational asthma and rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Exhaled breath molecular profiling by electronic nose in non-pulmonary malignancies Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Electronic nose versus exhaled no and bronchial challenge testing in asthma Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Exhaled breath collection by electronic nose: methods of measurement Source: Eur Respir J 2006; 28: Suppl. 50, 790s Year: 2006 Measurement of exhaled breath samples using an electronic nose: methodological issues Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009 Clinical usefulness of exhaled breath temperature in asthma control Source: Eur Respir J 2007; 30: Suppl. 51, 64s Year: 2007 Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath Source: ERS Lung Science Conference 2016 Year: 2016 Identification of COPD phenotypes using cluster analysis including exhaled air molecular profiling Source: Annual Congress 2010 - COPD: diagnosis Year: 2010 Proteins in exhaled air in assessment of asthma in children Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Early detection of patients with asthma or chronic bronchitis by investigation on exhaled air condensate Source: Eur Respir J 2002; 20: Suppl. 38, 275s Year: 2002